{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T15:48:45Z","timestamp":1763048925144,"version":"3.45.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012331","name":"LEO Fondet","doi-asserted-by":"publisher","award":["LF-ST-21-500002"],"award-info":[{"award-number":["LF-ST-21-500002"]}],"id":[{"id":"10.13039\/501100012331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF23SA0087869"],"award-info":[{"award-number":["NNF23SA0087869"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s40257-025-00978-0","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T17:38:16Z","timestamp":1755365896000},"page":"953-966","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psoriasis: Considerations for the Management of Women of Childbearing Potential"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0812-4075","authenticated-orcid":false,"given":"Signe Agnete R\u00f8nde","family":"Kristensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0390-9151","authenticated-orcid":false,"given":"Amanda","family":"Kvist-Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-9680","authenticated-orcid":false,"given":"Lone","family":"Skov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"key":"978_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021;397:1301\u201315.","journal-title":"Lancet"},{"key":"978_CR2","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/s0190-9622(85)70188-0","volume":"13","author":"T Henseler","year":"1985","unstructured":"Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;13:450\u20136. https:\/\/doi.org\/10.1016\/s0190-9622(85)70188-0.","journal-title":"J Am Acad Dermatol"},{"key":"978_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2340\/00015555-2171","volume":"96","author":"A L\u00f8nnberg","year":"2016","unstructured":"L\u00f8nnberg A, Skov L, Duffy D, Skytthe A, Kyvik K, Pedersen O, et al. Genetic factors explain variation in the age at onset of psoriasis: a population-based twin study. Acta Dermato-Venereol. 2016;96:35\u20138. https:\/\/doi.org\/10.2340\/00015555-2171.","journal-title":"Acta Dermato-Venereol"},{"key":"978_CR4","doi-asserted-by":"publisher","first-page":"AB65","DOI":"10.1016\/j.jaad.2019.06.265","volume":"81","author":"J Murase","year":"2019","unstructured":"Murase J, De Simone C, Fischer-Betz R, Ecoffet C, Tincani A. Fears and misconceptions of women with chronic inflammatory diseases on their journey to motherhood. J Am Acad Dermatol. 2019;81:AB65. https:\/\/doi.org\/10.1016\/j.jaad.2019.06.265.","journal-title":"J Am Acad Dermatol"},{"key":"978_CR5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.contraception.2011.07.013","volume":"84","author":"LB Finer","year":"2011","unstructured":"Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception. 2011;84:478\u201385. https:\/\/doi.org\/10.1016\/j.contraception.2011.07.013.","journal-title":"Contraception"},{"key":"978_CR6","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1111\/jdv.16915","volume":"34","author":"A Nast","year":"2020","unstructured":"Nast A, Smith C, Spuls PI, Avila Valle G, Bata-Cs\u00f6rg\u00f6 Z, Boonen H, et al. Euroguiderm guideline on the systemic treatment of psoriasis vulgaris\u2014part 1: treatment and monitoring recommendations. J Eur Acad Dermatol Venereol. 2020;34:2461\u201398. https:\/\/doi.org\/10.1111\/jdv.16915.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"978_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/jdv.16926","volume":"35","author":"A Nast","year":"2021","unstructured":"Nast A, Smith C, Spuls PI, Avila Valle G, Bata-Cs\u00f6rg\u00f6 Z, Boonen H, et al. Euroguiderm guideline on the systemic treatment of Psoriasis vulgaris\u2014part 2: specific clinical and comorbid situations. J Eur Acad Dermatol Venereol. 2021;35:281\u2013317. https:\/\/doi.org\/10.1111\/jdv.16926.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"978_CR8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1365-2133.2011.10513.x","volume":"165","author":"C-C Chi","year":"2011","unstructured":"Chi C-C, Kirtschig G, Aberer W, Gabbud J-P, Lipozen\u010di\u0107 J, K\u00e1rp\u00e1ti S, et al. Evidence-based (S3) guideline on topical corticosteroids in pregnancy. Br J Dermatol. 2011;165:943\u201352. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10513.x.","journal-title":"Br J Dermatol"},{"key":"978_CR9","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","volume":"80","author":"A Menter","year":"2019","unstructured":"Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80:1029\u201372. https:\/\/doi.org\/10.1016\/j.jaad.2018.11.057.","journal-title":"J Am Acad Dermatol"},{"key":"978_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jaad.2019.04.042","volume":"81","author":"CA Elmets","year":"2019","unstructured":"Elmets CA, Lim HW, Stoff B, Connor C, Cordoro KM, Lebwohl M, et al. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy. J Am Acad Dermatol. 2019;81:775\u2013804. https:\/\/doi.org\/10.1016\/j.jaad.2019.04.042.","journal-title":"J Am Acad Dermatol"},{"key":"978_CR11","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.jaad.2020.02.044","volume":"82","author":"A Menter","year":"2020","unstructured":"Menter A, Gelfand JM, Connor C, Armstrong AW, Cordoro KM, Davis DMR, et al. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies. J Am Acad Dermatol. 2020;82:1445\u201386. https:\/\/doi.org\/10.1016\/j.jaad.2020.02.044.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"978_CR12","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jaad.2020.07.087","volume":"84","author":"CA Elmets","year":"2021","unstructured":"Elmets CA, Korman NJ, Prater EF, Wong EB, Rupani RN, Kivelevitch D, et al. Joint AAD\u2013NPF guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J Am Acad Dermatol. 2021;84(2):432\u201370. https:\/\/doi.org\/10.1016\/j.jaad.2020.07.087.","journal-title":"J Am Acad Dermatol"},{"key":"978_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jaad.2023.10.072","volume":"91","author":"P McMullan","year":"2024","unstructured":"McMullan P, Yaghi M, Truong TM, Rothe M, Murase J, Grant-Kels JM. Safety of dermatologic medications in pregnancy and lactation: an update\u2014part I: pregnancy. J Am Acad Dermatol. 2024;91:619\u201348. https:\/\/doi.org\/10.1016\/j.jaad.2023.10.072.","journal-title":"J Am Acad Dermatol"},{"key":"978_CR14","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jaad.2023.10.071","volume":"91","author":"M Yaghi","year":"2024","unstructured":"Yaghi M, McMullan P, Truong TM, Rothe M, Murase J, Grant-Kels JM. Safety of dermatologic medications in pregnancy and lactation: an update\u2014part II: lactation. J Am Acad Dermatol. 2024;91:651\u201368. https:\/\/doi.org\/10.1016\/j.jaad.2023.10.071.","journal-title":"J Am Acad Dermatol"},{"unstructured":"Content and Format of Labeling for Human Prescription Drug and Biological Products. http:\/\/federalregister.gov\/a\/. Accessed 6 Mar 2025.","key":"978_CR15"},{"key":"978_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/ski2.199","author":"R Salle","year":"2023","unstructured":"Salle R, Halioua B, Le Fur G, Aubert R, Shourick J, Taieb C. Psoriasis and sexuality: patients express their feelings. Skin Health Dis. 2023. https:\/\/doi.org\/10.1002\/ski2.199.","journal-title":"Skin Health Dis"},{"key":"978_CR17","doi-asserted-by":"publisher","first-page":"T10","DOI":"10.1016\/j.ad.2023.10.030","volume":"115","author":"N Jim\u00e9nez G\u00f3mez","year":"2024","unstructured":"Jim\u00e9nez G\u00f3mez N, Gonz\u00e1lez-Cantero \u00c1, Ruiz-Villaverde R, Llamas-Velasco M, de la Cueva DP, Rivera D\u00edaz R, et al. [Translated article] Family planning concerns among women with psoriasis: a descriptive, cross-sectional, multicenter study. Actas Dermosifiliogr. 2024;115:T10\u201320. https:\/\/doi.org\/10.1016\/j.ad.2023.10.030.","journal-title":"Actas Dermosifiliogr"},{"key":"978_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/JW9.0000000000000189","volume":"11","author":"Y Yamaguchi","year":"2025","unstructured":"Yamaguchi Y, Spelman L, Mizutani Y, Lukowski B, Lanzafame A, Smith A. Management of psoriasis in women 18 to 45 years of age in Australia and Japan: insights from patient and dermatologist surveys. Int J Womens Dermatol. 2025;11: e189. https:\/\/doi.org\/10.1097\/JW9.0000000000000189.","journal-title":"Int J Womens Dermatol"},{"key":"978_CR19","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s40744-021-00348-2","volume":"8","author":"CB Johansen","year":"2021","unstructured":"Johansen CB, Laurberg TB, Egeberg A, Jensen U-FA, Hansen AL, Skov L, et al. Awareness and expectations surrounding family planning and pregnancy among Danish patients with chronic inflammatory disease of the skin or joints: results from an online survey. Rheumatol Ther. 2021;8:1419\u201333. https:\/\/doi.org\/10.1007\/s40744-021-00348-2.","journal-title":"Rheumatol Ther"},{"key":"978_CR20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ijwd.2021.08.011","volume":"7","author":"SR McBride","year":"2021","unstructured":"McBride SR, Fargnoli MC, Fougerousse A-C, Garc\u00eda Bust\u00ednduy M, Catton L, Senturk L, et al. Impact of psoriatic disease on women aged 18 to 45: results from a multinational survey across 11 European countries. Int J Womens Dermatol. 2021;7:697\u2013707. https:\/\/doi.org\/10.1016\/j.ijwd.2021.08.011.","journal-title":"Int J Womens Dermatol"},{"key":"978_CR21","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2147\/CCID.S275512","volume":"13","author":"F Maccari","year":"2020","unstructured":"Maccari F, Fougerousse AC, Reguiai Z, Taieb C. Contraception, sexuality and pregnancy in women with psoriasis: real-life experience of 235 women. Clin Cosmet Investig Dermatol. 2020;13:817\u201323. https:\/\/doi.org\/10.2147\/CCID.S275512.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"978_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jaad.2017.05.019","volume":"77","author":"S Singh","year":"2017","unstructured":"Singh S, Taylor C, Kornmehl H, Armstrong AW. Psoriasis and suicidality: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77:425-440.e2. https:\/\/doi.org\/10.1016\/j.jaad.2017.05.019.","journal-title":"J Am Acad Dermatol"},{"key":"978_CR23","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/J.JAAD.2004.04.014","volume":"51","author":"JM Gelfand","year":"2004","unstructured":"Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol. 2004;51:704\u20138. https:\/\/doi.org\/10.1016\/J.JAAD.2004.04.014.","journal-title":"J Am Acad Dermatol"},{"key":"978_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000090652","volume":"212","author":"M Esposito","year":"2006","unstructured":"Esposito M, Saraceno R, Giunta A, Maccarone M, Chimenti S. An Italian study on psoriasis and depression. Dermatology. 2006;212:123\u20137. https:\/\/doi.org\/10.1159\/000090652.","journal-title":"Dermatology"},{"key":"978_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/JW9.0000000000000176","volume":"10","author":"N da Silva Burger","year":"2024","unstructured":"da Silva Burger N, Augustin M, Westphal L, K\u00fchl L, Stephan B, Sommer R. Patient needs in women of childbearing age with psoriasis: retrospective analysis from the German PsoBest registry. Int J Womens Dermatol. 2024;10: e176. https:\/\/doi.org\/10.1097\/JW9.0000000000000176.","journal-title":"Int J Womens Dermatol"},{"key":"978_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ijwd.2019.04.021","volume":"5","author":"AB Gottlieb","year":"2019","unstructured":"Gottlieb AB, Ryan C, Murase JE. Clinical considerations for the management of psoriasis in women. Int J Womens Dermatol. 2019;5:141\u201350. https:\/\/doi.org\/10.1016\/j.ijwd.2019.04.021.","journal-title":"Int J Womens Dermatol"},{"key":"978_CR27","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v104.42441","volume":"104","author":"MB Jensen","year":"2024","unstructured":"Jensen MB, Loft N, Zacheriae C, Skov L. Sex differences in dermatology life quality index (DLQI) among patients with psoriasis. Acta Derm Venereol. 2024;104: adv42441. https:\/\/doi.org\/10.2340\/actadv.v104.42441.","journal-title":"Acta Derm Venereol"},{"key":"978_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00403-020-02066-1","volume":"313","author":"C Murer","year":"2021","unstructured":"Murer C, Sgier D, Mettler SK, Guillet C, Maul J-T, Djamei V, et al. Gender differences in psoriasis: a Swiss online psoriasis survey. Arch Dermatol Res. 2021;313:89\u201394. https:\/\/doi.org\/10.1007\/s00403-020-02066-1.","journal-title":"Arch Dermatol Res"},{"key":"978_CR29","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jaad.2016.10.040","volume":"76","author":"M Hawro","year":"2017","unstructured":"Hawro M, Maurer M, Weller K, Maleszka R, Zalewska-Janowska A, Kaszuba A, et al. Lesions on the back of hands and female gender predispose to stigmatization in patients with psoriasis. J Am Acad Dermatol. 2017;76:648-654.e2. https:\/\/doi.org\/10.1016\/j.jaad.2016.10.040.","journal-title":"J Am Acad Dermatol"},{"key":"978_CR30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1468-3083.2012.04451.x","volume":"27","author":"D B\u00f6hm","year":"2013","unstructured":"B\u00f6hm D, Stock Gissendanner S, Bangemann K, Snitjer I, Werfel T, Weyergraf A, et al. Perceived relationships between severity of psoriasis symptoms, gender, stigmatization and quality of life. J Eur Acad Dermatol Venereol. 2013;27:220\u20136. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04451.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"978_CR31","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/j.1365-2133.2011.10249.x","volume":"164","author":"KAP Meeuwis","year":"2011","unstructured":"Meeuwis KAP, de Hullu JA, van de Nieuwenhof HP, Evers AWM, Massuger LFAG, van de Kerkhof PCM, et al. Quality of life and sexual health in patients with genital psoriasis. Br J Dermatol. 2011;164:1247\u201355. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10249.x.","journal-title":"Br J Dermatol"},{"key":"978_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1001\/jamadermatol.2018.3442","volume":"155","author":"A Molina-Leyva","year":"2019","unstructured":"Molina-Leyva A, Salvador-Rodriguez L, Martinez-Lopez A, Ruiz-Carrascosa JC, Arias-Santiago S. Association between psoriasis and sexual and erectile dysfunction in epidemiologic studies. JAMA Dermatol. 2019;155:98. https:\/\/doi.org\/10.1001\/jamadermatol.2018.3442.","journal-title":"JAMA Dermatol"},{"key":"978_CR33","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jaad.2015.02.1127","volume":"72","author":"C Ryan","year":"2015","unstructured":"Ryan C, Sadlier M, De Vol E, Patel M, Lloyd AA, Day A, et al. Genital psoriasis is associated with significant impairment in quality of life and sexual functioning. J Am Acad Dermatol. 2015;72:978\u201383.","journal-title":"J Am Acad Dermatol"},{"key":"978_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-025-00944-w","author":"U Mrowietz","year":"2025","unstructured":"Mrowietz U, Meyer C, Gro\u00dfsch\u00e4dl K, Weger W, Wolf P, Gooderham M, et al. Burden to partners of people with psoriasis: results from the FamilyPso international study. Am J Clin Dermatol. 2025. https:\/\/doi.org\/10.1007\/s40257-025-00944-w.","journal-title":"Am J Clin Dermatol"},{"key":"978_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s13671-013-0066-6","volume":"3","author":"R Gupta","year":"2014","unstructured":"Gupta R, Debbaneh MG, Liao W. Genetic epidemiology of psoriasis. Curr Dermatol Rep. 2014;3:61\u201378. https:\/\/doi.org\/10.1007\/s13671-013-0066-6.","journal-title":"Curr Dermatol Rep"},{"key":"978_CR36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370:263\u201371. https:\/\/doi.org\/10.1016\/S0140-6736(07)61128-3.","journal-title":"Lancet"},{"key":"978_CR37","doi-asserted-by":"publisher","DOI":"10.1530\/REP-24-0197","volume":"169","author":"S Ameho","year":"2025","unstructured":"Ameho S, Klutstein M. The effect of chronic inflammation on female fertility. Reproduction. 2025;169:240197. https:\/\/doi.org\/10.1530\/REP-24-0197.","journal-title":"Reproduction"},{"key":"978_CR38","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1001\/JAMADERMATOL.2023.1400","volume":"159","author":"TC Chen","year":"2023","unstructured":"Chen TC, Iskandar IYK, Parisi R, Pierce M, Tower C, Kleyn CE, et al. Fertility trends and adverse pregnancy outcomes in female patients with psoriasis in the UK. JAMA Dermatol. 2023;159:736. https:\/\/doi.org\/10.1001\/JAMADERMATOL.2023.1400.","journal-title":"JAMA Dermatol"},{"key":"978_CR39","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/BJD.18164","volume":"181","author":"A Gonzalez-Cantero","year":"2019","unstructured":"Gonzalez-Cantero A, Carretero G, Rivera R, Ferr\u00e1ndiz C, Daud\u00e9n E, de la Cueva P, et al. Women with moderate-to-severe psoriasis in Spain (BIOBADADERM registry) show more than a 50% reduction in age-adjusted fertility rate when compared with the general population. Br J Dermatol. 2019;181:1085\u20137. https:\/\/doi.org\/10.1111\/BJD.18164.","journal-title":"Br J Dermatol"},{"key":"978_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jamadermatol.2020.5595","volume":"157","author":"AB Kimball","year":"2021","unstructured":"Kimball AB, Guenther L, Kalia S, de Jong EMGJ, Lafferty KP, Chen DY, et al. Pregnancy outcomes in women with moderate-to-severe psoriasis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR). JAMA Dermatol. 2021;157:301. https:\/\/doi.org\/10.1001\/jamadermatol.2020.5595.","journal-title":"JAMA Dermatol"},{"key":"978_CR41","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1404a221","volume":"14","author":"M Burlando","year":"2024","unstructured":"Burlando M, Salvi I, Poddine G, Cozzani E, Parodi A. Impact of psoriasis on pregnancy desire and possible consequences on fertility. Dermatol Pract Concept. 2024;14: e2024221. https:\/\/doi.org\/10.5826\/dpc.1404a221.","journal-title":"Dermatol Pract Concept"},{"key":"978_CR42","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jdin.2022.03.009","volume":"7","author":"CB Johansen","year":"2022","unstructured":"Johansen CB, Egeberg A, Jimenez-Solem E, Skov L, Thomsen SF. Psoriasis and adverse pregnancy outcomes: a nationwide case-control study in 491,274 women in Denmark. JAAD Int. 2022;7:146\u201355. https:\/\/doi.org\/10.1016\/j.jdin.2022.03.009.","journal-title":"JAAD Int"},{"key":"978_CR43","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jaad.2019.05.099","volume":"82","author":"M Lambe","year":"2020","unstructured":"Lambe M, Bergstrom AV, Johansson ALV, Weibull CE. Reproductive patterns and maternal and pregnancy outcomes in women with psoriasis\u2014a population-based study. J Am Acad Dermatol. 2020;82:1109\u201316. https:\/\/doi.org\/10.1016\/j.jaad.2019.05.099.","journal-title":"J Am Acad Dermatol"},{"key":"978_CR44","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/jid.2014.35","volume":"134","author":"E Harder","year":"2014","unstructured":"Harder E, Andersen A-MN, Kamper-J\u00f8rgensen M, Skov L. No increased risk of fetal death or prolonged time to pregnancy in women with psoriasis. J Invest Dermatol. 2014;134:1747\u20139. https:\/\/doi.org\/10.1038\/jid.2014.35.","journal-title":"J Invest Dermatol"},{"key":"978_CR45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000096910","volume":"214","author":"JD Seeger","year":"2007","unstructured":"Seeger JD, Lanza LL, West WA, Fernandez C, Rivero E. Pregnancy and pregnancy outcome among women with inflammatory skin diseases. Dermatology. 2007;214:32\u20139. https:\/\/doi.org\/10.1159\/000096910.","journal-title":"Dermatology"},{"key":"978_CR46","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.fertnstert.2012.10.040","volume":"99","author":"F Moro","year":"2013","unstructured":"Moro F, De Simone C, Morciano A, Tropea A, Sagnella F, Palla C, et al. Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis. Fertil Steril. 2013;99:936\u201342. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.10.040.","journal-title":"Fertil Steril"},{"key":"978_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9061947","volume":"9","author":"T-H Lee","year":"2020","unstructured":"Lee T-H, Wu C-H, Chen M-L, Yip H-T, Lee C-I, Lee M-S, et al. Risk of psoriasis in patients with polycystic ovary syndrome: a national population-based cohort study. J Clin Med. 2020;9: 1947. https:\/\/doi.org\/10.3390\/jcm9061947.","journal-title":"J Clin Med"},{"key":"978_CR48","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejogrb.2015.06.002","volume":"191","author":"F Moro","year":"2015","unstructured":"Moro F, Tropea A, Scarinci E, Federico A, De Simone C, Caldarola G, et al. Psoriasis and polycystic ovary syndrome: a new link in different phenotypes. Eur J Obstet Gynecol Reprod Biol. 2015;191:101\u20135. https:\/\/doi.org\/10.1016\/j.ejogrb.2015.06.002.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"978_CR49","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.fertnstert.2011.07.022","volume":"96","author":"JF McLaren","year":"2011","unstructured":"McLaren JF, Haynes K, Barnhart KT, Sammel MD, Strom BL. Early menopause in women with chronic inflammatory disease: a population-based cohort study. Fertil Steril. 2011;96:S3\u20134. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.07.022.","journal-title":"Fertil Steril"},{"key":"978_CR50","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.tjog.2018.02.010","volume":"57","author":"B Tu\u011frul Ayano\u011flu","year":"2018","unstructured":"Tu\u011frul Ayano\u011flu B, \u00d6zdemir ED, T\u00fcrko\u011flu O, Alhan A. Diminished ovarian reserve in patients with psoriasis. Taiwan J Obstet Gynecol. 2018;57:227\u201330. https:\/\/doi.org\/10.1016\/j.tjog.2018.02.010.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"978_CR51","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1080\/09513590.2018.1563884","volume":"35","author":"B Aydogan Mathyk","year":"2019","unstructured":"Aydogan Mathyk B, Aslan Cetin B, Bilici S, Fasse J, Avci P. Evaluation of ovarian reserve in women with psoriasis. Gynecol Endocrinol. 2019;35:608\u201311. https:\/\/doi.org\/10.1080\/09513590.2018.1563884.","journal-title":"Gynecol Endocrinol"},{"key":"978_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgae828","volume":"00","author":"V Wang","year":"2024","unstructured":"Wang V, Walsh JA, Zell J, Verrilli LE, Letourneau JM, Johnstone EB, et al. Autoimmune disease is increased in women with primary ovarian insufficiency. J Clin Endocrinol Metab. 2024;00:1\u20137. https:\/\/doi.org\/10.1210\/clinem\/dgae828.","journal-title":"J Clin Endocrinol Metab"},{"key":"978_CR53","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1365-2133.2010.09899.x","volume":"163","author":"G Bandoli","year":"2010","unstructured":"Bandoli G, Johnson DL, Jones KL, Lopez Jiminez J, Salas E, Mirrasoul N, et al. Potentially modifiable risk factors for adverse pregnancy outcomes in women with psoriasis. Br J Dermatol. 2010;163:334\u20139. https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09899.x.","journal-title":"Br J Dermatol"},{"key":"978_CR54","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/humrep\/13.6.1532","volume":"13","author":"C Augood","year":"1998","unstructured":"Augood C, Duckitt K, Templeton AA. Smoking and female infertility: a systematic review and meta-analysis. Hum Reprod. 1998;13:1532\u20139. https:\/\/doi.org\/10.1093\/humrep\/13.6.1532.","journal-title":"Hum Reprod"},{"key":"978_CR55","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1055\/s-0031-1293204","volume":"29","author":"C Boots","year":"2011","unstructured":"Boots C, Stephenson MD. Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review. Semin Reprod Med. 2011;29:507\u201313. https:\/\/doi.org\/10.1055\/s-0031-1293204.","journal-title":"Semin Reprod Med"},{"key":"978_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-043960","volume":"11","author":"S Murray","year":"2021","unstructured":"Murray S, Augustyniak M, Murase JE, Fischer-Betz R, Nelson-Piercy C, Peniuta M, et al. Barriers to shared decision-making with women of reproductive age affected by a chronic inflammatory disease: a mixed-methods needs assessment of dermatologists and rheumatologists. BMJ Open. 2021;11: e043960. https:\/\/doi.org\/10.1136\/bmjopen-2020-043960.","journal-title":"BMJ Open"},{"key":"978_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2025.02.010","author":"A Singal","year":"2025","unstructured":"Singal A, Lipner SR. Topical corticosteroid exposure is not associated with increased risk of pregnancy complications in a large population-based cohort study of psoriasis patients. J Am Acad Dermatol. 2025. https:\/\/doi.org\/10.1016\/j.jaad.2025.02.010.","journal-title":"J Am Acad Dermatol"},{"unstructured":"European Medicines Agency. Nordimet summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/nordimet-epar-product-information_en.pdf. Accessed 5 Feb 2025.","key":"978_CR58"},{"unstructured":"European Medicines Agency. Humira summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/humira-epar-product-information_en.pdf. Accessed 5 Feb 2025.","key":"978_CR59"},{"unstructured":"European Medicines Agency. Remicade summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/remicade-epar-product-information_en.pdf. Accessed 5 Feb 2025.","key":"978_CR60"},{"unstructured":"European Medicines Agency. Cimzia summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/cimzia-epar-product-information_en.pdf. Accessed 5 Feb 2025.","key":"978_CR61"},{"unstructured":"European Medicines Agency. Enbrel summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/enbrel-epar-product-information_en.pdf. Accessed 5 Feb 2025.","key":"978_CR62"},{"unstructured":"Genus Pharmaceuticals, Summary of Product Characteristics. Acitretin 25 mg Capsules\u2014Summary of Product Characteristics (SmPC) - print friendly\u2014(emc). https:\/\/www.medicines.org.uk\/emc\/product\/5264\/smpc\/print. Accessed 23 July 2025.","key":"978_CR63"},{"unstructured":"Novartis. Sandimmune\u00ae (cyclosporine capsules, USP) Prescribing Information. https:\/\/www.novartis.com\/us-en\/sites\/novartis_us\/files\/sandimmune.pdf. Accessed 8 June 2025.","key":"978_CR64"},{"unstructured":"European Medicines Agency. Bimzelx summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/bimzelx-epar-product-information_en.pdf. Accessed 5 Feb 2025.","key":"978_CR65"},{"unstructured":"European Medicines Agency. Cosentyx summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/cosentyx-epar-product-information_en.pdf. Accessed 5 Feb 2025.","key":"978_CR66"},{"unstructured":"European Medicines Agency. Kyntheum summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/kyntheum-epar-product-information_en.pdf. Accessed 5 Feb 2025.","key":"978_CR67"},{"unstructured":"European Medicines Agency. Taltz summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/taltz-epar-product-information_en.pdf. Accessed 5 Feb 2025.","key":"978_CR68"},{"unstructured":"European Medicines Agency. Stelara summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/stelara-epar-product-information_en.pdf. Accessed 5 Feb 2025.","key":"978_CR69"},{"unstructured":"European Medicines Agency. Skyrizi summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/skyrizi-epar-product-information_en.pdf. Accessed 5 Feb 2025.","key":"978_CR70"},{"unstructured":"European Medicines Agency. Tremfya summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/tremfya-epar-product-information_en.pdf. Accessed 5 Feb 2025.","key":"978_CR71"},{"unstructured":"European Medicines Agency. Ilumetri summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/ilumetri-epar-product-information_en.pdf. Accessed 5 Feb 2025.","key":"978_CR72"},{"key":"978_CR73","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1046\/j.1365-4362.2003.01760.x","volume":"42","author":"SP Raychaudhuri","year":"2003","unstructured":"Raychaudhuri SP, Navare T, Gross J, Raychaudhuri SK. Clinical course of psoriasis during pregnancy. Int J Dermatol. 2003;42:518\u201320. https:\/\/doi.org\/10.1046\/j.1365-4362.2003.01760.x.","journal-title":"Int J Dermatol"},{"key":"978_CR74","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.5.601","author":"JE Murase","year":"2005","unstructured":"Murase JE, Chan KK, Garite TJ, Cooper DM, Weinstein GD. Hormonal effect on psoriasis in pregnancy and post partum. Arch Dermatol. 2005. https:\/\/doi.org\/10.1001\/archderm.141.5.601.","journal-title":"Arch Dermatol"},{"key":"978_CR75","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17434","author":"U Mrowietz","year":"2021","unstructured":"Mrowietz U, Dieckmann T, Gerdes S, Szymczak S, Von Spreckelsen R, K\u00f6rber A. ActiPso: definition of activity types for psoriatic disease: a novel marker for an advanced disease classification. J Eur Acad Dermatol Venereol. 2021. https:\/\/doi.org\/10.1111\/jdv.17434.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"978_CR76","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s00404-022-06463-x","volume":"306","author":"KD Allen","year":"2022","unstructured":"Allen KD, Kiefer MK, Butnariu M, Afzali A. Pregnant women with immune mediated inflammatory diseases who discontinue biologics have higher rates of disease flare. Arch Gynecol Obstet. 2022;306:1929\u201337. https:\/\/doi.org\/10.1007\/s00404-022-06463-x.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"978_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14020582","volume":"14","author":"F Cassalia","year":"2025","unstructured":"Cassalia F, Lunardon A, Frattin G, Danese A, Caroppo F, Fortina AB. How hormonal balance changes lives in women with psoriasis. J Clin Med. 2025;14(2): 582. https:\/\/doi.org\/10.3390\/jcm14020582.","journal-title":"J Clin Med"},{"key":"978_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.672168","volume":"12","author":"S Hellberg","year":"2021","unstructured":"Hellberg S, Raffetseder J, Rundquist O, Magnusson R, Papapavlou G, Jenmalm MC, et al. Progesterone dampens immune responses in in vitro activated CD4+ T cells and affects genes associated with autoimmune diseases that improve during pregnancy. Front Immunol. 2021;12:1. https:\/\/doi.org\/10.3389\/fimmu.2021.672168.","journal-title":"Front Immunol"},{"key":"978_CR79","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/CED.15105","volume":"47","author":"CB Johansen","year":"2022","unstructured":"Johansen CB, Egeberg A, Jimenez-Solem E, Skov L, Thomsen SF. Association of maternal psoriasis and small for gestational age or preterm birth: a nationwide matched cohort study in 69 080 singleton infants. Clin Exp Dermatol. 2022;47:1115\u201323. https:\/\/doi.org\/10.1111\/CED.15105.","journal-title":"Clin Exp Dermatol"},{"key":"978_CR80","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1186\/s12884-023-06006-5","volume":"23","author":"S Rahmati","year":"2023","unstructured":"Rahmati S, Moameri H, Mohammadi NM, Norouzi M, Ghalekhani N, Beigzadeh A, et al. Impact of maternal psoriasis on adverse maternal and neonatal outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2023;23:703. https:\/\/doi.org\/10.1186\/s12884-023-06006-5.","journal-title":"BMC Pregnancy Childbirth"},{"key":"978_CR81","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/JAMADERMATOL.2021.1090","volume":"157","author":"NW Andersson","year":"2021","unstructured":"Andersson NW, Skov L, Andersen JT. Evaluation of topical corticosteroid use in pregnancy and risk of newborns being small for gestational age and having low birth weight. JAMA Dermatol. 2021;157:788. https:\/\/doi.org\/10.1001\/JAMADERMATOL.2021.1090.","journal-title":"JAMA Dermatol"},{"unstructured":"European Medicines Agency. Simponi summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/simponi-epar-product-information_en.pdf. Accessed 5 Feb 2025.","key":"978_CR82"},{"key":"978_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/J.ARD.2025.02.023\/ATTACHMENT\/F70D0B7C-2042-4EC5-9804-3288AF1E37D3\/MMC1.DOCX","author":"L R\u00fcegg","year":"2025","unstructured":"R\u00fcegg L, Pluma A, Hamroun S, Cecchi I, Perez-Garcia LF, Anderson PO, et al. EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update. Ann Rheum Dis. 2025. https:\/\/doi.org\/10.1016\/J.ARD.2025.02.023\/ATTACHMENT\/F70D0B7C-2042-4EC5-9804-3288AF1E37D3\/MMC1.DOCX.","journal-title":"Ann Rheum Dis"},{"unstructured":"List of Pregnancy Exposure Registries | FDA. https:\/\/www.fda.gov\/consumers\/pregnancy-exposure-registries\/list-pregnancy-exposure-registries. Accessed 8 June 2025.","key":"978_CR84"},{"key":"978_CR85","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-4362.1996.tb01632.x","volume":"35","author":"AS Boyd","year":"1996","unstructured":"Boyd AS, Morris LF, Phillips CM, Menter MA. Psoriasis and pregnancy: hormone and immune system interaction. Int J Dermatol. 1996;35:169\u201372. https:\/\/doi.org\/10.1111\/j.1365-4362.1996.tb01632.x.","journal-title":"Int J Dermatol"},{"key":"978_CR86","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1111\/JDV.17737","volume":"36","author":"R Rivera-Diaz","year":"2022","unstructured":"Rivera-Diaz R, Llamas-Velasco M, Carretero G, Ru\u00edz-Genao D, Belinch\u00f3n I, Riera-Monroig J, et al. Women with moderate-to-severe psoriasis in Spain (BIOBADADERM registry) breastfeed less when compared with general population. J Eur Acad Dermatol Venereol. 2022;36:e205\u20137. https:\/\/doi.org\/10.1111\/JDV.17737.","journal-title":"J Eur Acad Dermatol Venereol"},{"unstructured":"World Health Organization. Infant and young child feeding. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/infant-and-young-child-feeding. Accessed 7 Feb 2025.","key":"978_CR87"},{"key":"978_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/J.SEMPERI.2020.151380","volume":"45","author":"S Perrella","year":"2021","unstructured":"Perrella S, Gridneva Z, Lai CT, Stinson L, George A, Bilston-John S, et al. Human milk composition promotes optimal infant growth, development and health. Semin Perinatol. 2021;45: 151380. https:\/\/doi.org\/10.1016\/J.SEMPERI.2020.151380.","journal-title":"Semin Perinatol"},{"key":"978_CR89","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0140-6736(15)01024-7","volume":"387","author":"CG Victora","year":"2016","unstructured":"Victora CG, Bahl R, Barros AJD, Fran\u00e7a GVA, Horton S, Krasevec J, et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387:475\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(15)01024-7.","journal-title":"Lancet"},{"key":"978_CR90","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1016\/S2214-109X(15)70002-1","volume":"3","author":"CG Victora","year":"2015","unstructured":"Victora CG, Horta BL, de Mola CL, Quevedo L, Pinheiro RT, Gigante DP, et al. Association between breastfeeding and intelligence, educational attainment, and income at 30 years of age: a prospective birth cohort study from Brazil. Lancet Glob Health. 2015;3:e199\u2013205. https:\/\/doi.org\/10.1016\/S2214-109X(15)70002-1.","journal-title":"Lancet Glob Health"},{"key":"978_CR91","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.0421","volume":"6","author":"A Babic","year":"2020","unstructured":"Babic A, Sasamoto N, Rosner BA, Tworoger SS, Jordan SJ, Risch HA, et al. Association between breastfeeding and ovarian cancer risk. JAMA Oncol. 2020;6: e200421. https:\/\/doi.org\/10.1001\/jamaoncol.2020.0421.","journal-title":"JAMA Oncol"},{"key":"978_CR92","doi-asserted-by":"publisher","DOI":"10.1111\/1751-7915.14520","volume":"17","author":"AC Masi","year":"2024","unstructured":"Masi AC, Stewart CJ. Role of breastfeeding in disease prevention. Microb Biotechnol. 2024;17: e14520. https:\/\/doi.org\/10.1111\/1751-7915.14520.","journal-title":"Microb Biotechnol"},{"key":"978_CR93","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/mcn.12148","volume":"11","author":"G Thomson","year":"2015","unstructured":"Thomson G, Ebisch-Burton K, Flacking R. Shame if you do\u2014shame if you don\u2019t: women\u2019s experiences of infant feeding. Matern Child Nutr. 2015;11:33\u201346. https:\/\/doi.org\/10.1111\/mcn.12148.","journal-title":"Matern Child Nutr"},{"key":"978_CR94","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/10410236.2024.2344284","volume":"40","author":"SF Scott","year":"2025","unstructured":"Scott SF, Bute JJ. \u201cIt doesn\u2019t have to be all or nothing\u201d: how individuals who use infant formula understand the breastfeeding master narrative. Health Commun. 2025;40:321\u201331. https:\/\/doi.org\/10.1080\/10410236.2024.2344284.","journal-title":"Health Commun"},{"unstructured":"European Medicines Agency. Otezla summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/otezla-epar-product-information_en.pdf. Accessed 5 Feb 2025.","key":"978_CR95"},{"unstructured":"European Medicines Agency. Sotyktu summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/sotyktu-epar-product-information_en.pdf. Accessed 5 Feb 2025.","key":"978_CR96"},{"key":"978_CR97","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","volume":"4","author":"K Cheent","year":"2010","unstructured":"Cheent K, Nolan J, Shariq S, Kiho L, Pal A, Arnold J. Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn\u2019s disease. J Crohns Colitis. 2010;4:603\u20135. https:\/\/doi.org\/10.1016\/j.crohns.2010.05.001.","journal-title":"J Crohns Colitis"},{"key":"978_CR98","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.gastro.2016.04.002","volume":"151","author":"M Julsgaard","year":"2016","unstructured":"Julsgaard M, Christensen LA, Gibson PR, Gearry RB, Fallingborg J, Hvas CL, et al. Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection. Gastroenterology. 2016;151:110\u20139. https:\/\/doi.org\/10.1053\/j.gastro.2016.04.002.","journal-title":"Gastroenterology"},{"key":"978_CR99","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1586\/14760584.2016.1115351","volume":"15","author":"J Ling","year":"2016","unstructured":"Ling J, Koren G. Challenges in vaccinating infants born to mothers taking immunoglobulin biologicals during pregnancy. Expert Rev Vaccines. 2016;15:239\u201356. https:\/\/doi.org\/10.1586\/14760584.2016.1115351.","journal-title":"Expert Rev Vaccines"},{"key":"978_CR100","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023714","volume":"9","author":"NW Tsao","year":"2019","unstructured":"Tsao NW, Lynd LD, Sayre EC, Sadatsafavi M, Hanley G, De Vera MA. Use of biologics during pregnancy and risk of serious infections in the mother and baby: a Canadian population-based cohort study. BMJ Open. 2019;9: e023714. https:\/\/doi.org\/10.1136\/bmjopen-2018-023714.","journal-title":"BMJ Open"},{"key":"978_CR101","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/ibd\/izy294","volume":"25","author":"D Duricova","year":"2019","unstructured":"Duricova D, Dvorakova E, Hradsky O, Mitrova K, Durilova M, Kozeluhova J, et al. Safety of anti-TNF-alpha therapy during pregnancy on long-term outcome of exposed children: a controlled, multicenter observation. Inflamm Bowel Dis. 2019;25:789\u201396. https:\/\/doi.org\/10.1093\/ibd\/izy294.","journal-title":"Inflamm Bowel Dis"},{"key":"978_CR102","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/apt.15971","volume":"52","author":"G Br\u00f6ms","year":"2020","unstructured":"Br\u00f6ms G, Kieler H, Ekbom A, Gissler M, Hellgren K, Leinonen MK, et al. Paediatric infections in the first 3 years of life after maternal anti-TNF treatment during pregnancy. Aliment Pharmacol Ther. 2020;52:843\u201354. https:\/\/doi.org\/10.1111\/apt.15971.","journal-title":"Aliment Pharmacol Ther"},{"key":"978_CR103","doi-asserted-by":"publisher","first-page":"S-149","DOI":"10.1016\/s0016-5085(12)60561-7","volume":"142","author":"U Mahadevan","year":"2012","unstructured":"Mahadevan U, Martin CF, Sandler RS, Kane SV, Dubinsky M, Lewis JD, et al. 865 PIANO: a 1000 patient prospective registry of pregnancy outcomes in women with ibd exposed to immunomodulators and biologic therapy. Gastroenterology. 2012;142:S-149. https:\/\/doi.org\/10.1016\/s0016-5085(12)60561-7.","journal-title":"Gastroenterology"},{"key":"978_CR104","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s40272-022-00525-y","volume":"24","author":"CJ McKinzie","year":"2022","unstructured":"McKinzie CJ, Casale JP, Guerci JC, Prom A, Doligalski CT. Outcomes of children with fetal and lactation immunosuppression exposure born to female transplant recipients. Pediatr Drugs. 2022;24:483\u201397. https:\/\/doi.org\/10.1007\/s40272-022-00525-y.","journal-title":"Pediatr Drugs"},{"unstructured":"Statens Serum Institut. Childhood vaccination programme. https:\/\/en.ssi.dk\/vaccination\/the-danish-childhood-vaccination-programme. Accessed 24 July 2025.","key":"978_CR105"},{"unstructured":"U.S. Centers for Disease Control and Prevention. Your child needs vaccines as they grow! 2024. https:\/\/www.cdc.gov\/vaccines\/imz-schedules\/downloads\/parent-ver-sch-0-6yrs.pdf. Accessed 8 Mar 2025.","key":"978_CR106"},{"unstructured":"BCG vaccine for tuberculosis (TB)\u2014NHS. https:\/\/www.nhs.uk\/vaccinations\/bcg-vaccine-for-tuberculosis-tb\/. Accessed 14 Feb 2025.","key":"978_CR107"},{"key":"978_CR108","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/ecco-jcc\/jjad005","volume":"17","author":"JP Gisbert","year":"2023","unstructured":"Gisbert JP, Chaparro M. Vaccines in children exposed to biological agents in utero and\/or during breastfeeding: are they effective and safe? J Crohns Colitis. 2023;17:995\u20131009. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjad005.","journal-title":"J Crohns Colitis"},{"key":"978_CR109","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae048","volume":"18","author":"P Sousa","year":"2024","unstructured":"Sousa P, Gisbert JP, Julsgaard M, Selinger CP, Chaparro M. Navigating reproductive care in patients with inflammatory bowel disease: a comprehensive review. J Crohns Colitis. 2024;18: ii16\u2013ii30. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjae048.","journal-title":"J Crohns Colitis"},{"key":"978_CR110","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1093\/ecco-jcc\/jjaa099","volume":"14","author":"SH Park","year":"2020","unstructured":"Park SH, Kim HJ, Lee CK, Song EM, Kang S-B, Jang BI, et al. Safety and optimal timing of BCG vaccination in infants born to mothers receiving anti-TNF therapy for inflammatory bowel disease. J Crohns Colitis. 2020;14:1780\u20134. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa099.","journal-title":"J Crohns Colitis"},{"key":"978_CR111","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1093\/rheumatology\/keac141","volume":"61","author":"B Goulden","year":"2022","unstructured":"Goulden B, Chua N, Parker E, Giles I. A systematic review of live vaccine outcomes in infants exposed to biologic disease modifying anti-rheumatic drugs in utero. Rheumatology. 2022;61:3902\u20136. https:\/\/doi.org\/10.1093\/rheumatology\/keac141.","journal-title":"Rheumatology"},{"key":"978_CR112","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1093\/ecco-jcc\/jjac093","volume":"16","author":"Z Liu","year":"2022","unstructured":"Liu Z, Julsgaard M, Zhu X, Martin J, Barclay ML, Cranswick N, et al. Timing of live attenuated vaccination in infants exposed to infliximab or adalimumab in utero\u202f: a prospective cohort study in 107 children. J Crohns Colitis. 2022;16:1835\u201344. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjac093.","journal-title":"J Crohns Colitis"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-025-00978-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-025-00978-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-025-00978-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T15:45:41Z","timestamp":1763048741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-025-00978-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":112,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["978"],"URL":"https:\/\/doi.org\/10.1007\/s40257-025-00978-0","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"type":"print","value":"1175-0561"},{"type":"electronic","value":"1179-1888"}],"subject":[],"published":{"date-parts":[[2025,8,16]]},"assertion":[{"value":"31 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Kristensen and Dr. Kvist-Hansen declare no conflicts of interest. Dr. Skov has received research funding from Sanofi, Bristol-Myers Squibb, Almirall, Janssen, the Danish National Psoriasis Foundation, the LEO Foundation and the Kgl Hofbundtmager Aage Bang Foundation, and honoraria as consultant and\/or speaker for AbbVie, Eli Lilly, Novartis, Pfizer, LEO Pharma, Janssen, UCB, Almirall, Bristol-Myers Squibb, UCB Stada Takeda, and Sanofi. She has served as an investigator for AbbVie, Pfizer, Sanofi, Janssen, Boehringer Ingelheim, AstraZeneca, Eli Lilly, Novartis, Regeneron, Galderma, and LEO Pharma.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All the authors participated equally in the drafting of the manuscript. All the authors read and approved the final paper.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}